CN116621756A - Preparation method of 3, 3-difluoro-gamma-lactam compound - Google Patents
Preparation method of 3, 3-difluoro-gamma-lactam compound Download PDFInfo
- Publication number
- CN116621756A CN116621756A CN202310595622.2A CN202310595622A CN116621756A CN 116621756 A CN116621756 A CN 116621756A CN 202310595622 A CN202310595622 A CN 202310595622A CN 116621756 A CN116621756 A CN 116621756A
- Authority
- CN
- China
- Prior art keywords
- difluoro
- nmr
- gamma
- reaction
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 45
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims abstract description 29
- HGWXXIZVRRTDKT-UHFFFAOYSA-N ethyl 2,2-difluoro-2-iodoacetate Chemical compound CCOC(=O)C(F)(F)I HGWXXIZVRRTDKT-UHFFFAOYSA-N 0.000 claims abstract description 18
- UEQYFPCXXRUPKQ-UHFFFAOYSA-N azidoethene Chemical compound C=CN=[N+]=[N-] UEQYFPCXXRUPKQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims abstract description 5
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 125000003118 aryl group Chemical group 0.000 claims abstract description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- -1 methoxy, acetyl Chemical group 0.000 claims description 57
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 48
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 claims description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 16
- 229910052786 argon Inorganic materials 0.000 claims description 16
- 239000003208 petroleum Substances 0.000 claims description 16
- 239000000741 silica gel Substances 0.000 claims description 16
- 229910002027 silica gel Inorganic materials 0.000 claims description 16
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical group C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 239000004305 biphenyl Chemical group 0.000 claims description 3
- 235000010290 biphenyl Nutrition 0.000 claims description 3
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 2
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 2
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000005843 halogen group Chemical group 0.000 claims description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 2
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 7
- 238000006467 substitution reaction Methods 0.000 claims 1
- 238000003786 synthesis reaction Methods 0.000 abstract description 16
- 239000000758 substrate Substances 0.000 abstract description 3
- 230000007613 environmental effect Effects 0.000 abstract description 2
- 230000035484 reaction time Effects 0.000 abstract description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 42
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 42
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 40
- 238000003756 stirring Methods 0.000 description 22
- 229940125904 compound 1 Drugs 0.000 description 17
- 238000005160 1H NMR spectroscopy Methods 0.000 description 14
- 230000015572 biosynthetic process Effects 0.000 description 14
- 239000012043 crude product Substances 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 10
- 239000007787 solid Substances 0.000 description 10
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 5
- 238000007154 radical cyclization reaction Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 3
- 238000007342 radical addition reaction Methods 0.000 description 3
- CSCPPACGZOOCGX-MICDWDOJSA-N 1-deuteriopropan-2-one Chemical compound [2H]CC(C)=O CSCPPACGZOOCGX-MICDWDOJSA-N 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- CDHHTJIEVYLEFO-UHFFFAOYSA-N 1-(1-azidoethyl)-4-fluorobenzene Chemical compound [N-]=[N+]=NC(C)C1=CC=C(F)C=C1 CDHHTJIEVYLEFO-UHFFFAOYSA-N 0.000 description 1
- RHMXAMDVHXEDGU-UHFFFAOYSA-N 2,2-difluoro-2-iodoacetic acid Chemical compound OC(=O)C(F)(F)I RHMXAMDVHXEDGU-UHFFFAOYSA-N 0.000 description 1
- VQPZMYWSCFLCRG-UHFFFAOYSA-N 2-azidooct-1-ene Chemical compound C(=C)(CCCCCC)N=[N+]=[N-] VQPZMYWSCFLCRG-UHFFFAOYSA-N 0.000 description 1
- JMZQVDLGLPUVFU-UHFFFAOYSA-N 3-(1-azidoethyl)thiophene Chemical compound [N-]=[N+]=NC(C)C=1C=CSC=1 JMZQVDLGLPUVFU-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- LTVOKYUPTHZZQH-UHFFFAOYSA-N difluoromethane Chemical group F[C]F LTVOKYUPTHZZQH-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- GBCVLUBURHKDRI-UHFFFAOYSA-N methyl 4-(1-azidoethenyl)benzoate Chemical compound COC(=O)C1=CC=C(C(=C)N=[N+]=[N-])C=C1 GBCVLUBURHKDRI-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- HYANWYAFOHHLTB-UHFFFAOYSA-N n,n-difluoroacetamide Chemical class CC(=O)N(F)F HYANWYAFOHHLTB-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 150000003953 γ-lactams Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The application discloses a preparation method of a 3, 3-difluoro-gamma-lactam compound in the field of organic synthesis chemistry, which takes vinyl azide and ethyl difluoroiodoacetate as raw materials and uses Et as a raw material 2 In the presence of Zn, in anhydrous acetonitrile, reacting for 3 hours at the temperature of minus 10 ℃ to synthesize a series of 3, 3-difluoro-gamma-lactam compounds containing C-5 quaternary carbon centers, wherein the reaction formula is as follows:
Description
Technical Field
The application belongs to the field of organic synthetic chemistry, and particularly relates to a preparation method of a 3, 3-difluoro-gamma-lactam compound.
Background
The introduction of fluorine atoms or fluorine-containing groups, etc., into the organic compound will greatly improve the biological activity and physicochemical properties of the parent molecule. Wherein difluoromethylene (-CF) 2 ) As a representative fluorine-containing groupIt is considered a metabolically stable bioisostere of hydroxyl, thiol and carbonyl groups, and thus its introduction into target molecules is of continued interest to pharmaceutical chemists and synthetic chemists. Gamma-lactams are an important building block, are widely found in many natural products and drug molecules, and exhibit good antibacterial, antifungal and antitumor biological activities. The synthesis method of 3, 3-difluoro-gamma-lactam compound mainly comprises two types of intramolecular free radical cyclization reaction and free radical addition/intramolecular cyclization reaction. The method is characterized in that N-allyl bromodifluoroacetamide is used as a raw material, and 3, 3-difluoro-gamma-lactam compound is prepared through intramolecular free radical cyclization reaction under the catalysis of transition metal or the induction of visible light; the other is catalyst or oxidant Na of olefin and halogenated difluoro acetamide in transition metal 2 S 2 O 4 Under the action, amino difluoro alkylation of olefin is realized through intermolecular free radical addition/cyclization reaction, and the target 3, 3-difluoro-gamma-lactam compound is obtained.
1) Intramolecular radical cyclization reaction
2) Intermolecular radical addition/cyclization reaction
However, the above methods lack wide substrate versatility and synthetic practicality, have limitations for the preparation of complex derivatives, and are difficult to apply to the structural modification of drug molecules.
Disclosure of Invention
The application designs a preparation method of a 3, 3-difluoro-gamma-lactam compound aiming at the defects of the prior art.
An object of the present application is to provide a process for producing a 3, 3-difluoro-gamma-lactam compound from vinyl azide and ethyl difluoroiodoacetate as starting materials in Et 2 Zn presenceThen, a series of 3, 3-difluoro-gamma-lactam compounds containing C-5 quaternary carbon centers are synthesized by reacting for 3 hours at minus 10 ℃ in anhydrous acetonitrile, wherein the reaction formula is as follows:
wherein R is one of a substituted or unsubstituted aryl group and a substituted or unsubstituted alkyl group.
The aryl is phenyl, biphenyl, naphthyl, thienyl or furyl.
The alkyl is C1-C10 alkyl. Further C3-C6 alkyl.
Further, "substituted" in the "substituted or unsubstituted" means that at least one hydrogen atom on the group is substituted with a group selected from the group consisting of: hydrogen atom, halogen atom, methyl, ethyl, propyl, butyl, methoxy, acetyl, acetoxy, methoxycarbonyl, benzoyloxymethyl, tert-butyl, benzoyloxy.
Further, R is selected from phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 4-methylphenyl, 4-ethylphenyl, 4-methoxyphenyl, 4-acetylphenyl, 4-acetoxyphenyl, 4-methoxycarbonylphenyl, 4-benzoyloxymethylphenyl, 4-t-butylphenyl, biphenyl, 3-methylphenyl, 3-bromophenyl; 3-thienyl, 5-benzofuranyl, cyclohexyl, n-hexyl, 4-methoxycarbonyl n-butyl or 3-benzoyloxy n-propyl.
Further, the above reaction was carried out under argon.
Further, after the reaction is finished, concentrating under vacuum; eluting with petroleum ether/ethyl acetate, and separating with silica gel column to obtain 3, 3-difluoro-gamma-lactam compound.
Further, the molar ratio of ethyl difluoroiodoacetate to vinyl azide is 1.2:1.
Further, the Et 2 The molar ratio of Zn to vinyl azide was 0.5:1.
Further, the solvent anhydrous acetonitrile was added in an amount 200 times that of the vinyl azide compound.
The application has the beneficial effects that: the application mainly provides a synthesis method of the 3, 3-difluoro-gamma-lactam compound, which has the advantages of mild reaction conditions, high step economy, high atom economy, short reaction time, good substrate universality, easily obtained raw materials, environmental friendliness and the like.
The second object of the present application is to provide a series of compounds shown in 1 a-1 n, which are novel compounds, and since 3, 3-difluoro-gamma-lactam compounds are an important type of framework structure, they have wide application in the fields of organic synthesis and pharmaceutical chemistry.
Drawings
FIG. 1 is a 1H-NMR chart of compound 1 a.
FIG. 2 is a 13C-NMR chart of compound 1 a.
FIG. 3 is a 1H-NMR chart of compound 1 b.
FIG. 4 is a 13C-NMR chart of compound 1 b.
FIG. 5 is a 1H-NMR chart of compound 1 c.
FIG. 6 is a 13C-NMR chart of compound 1C.
FIG. 7 is a 1H-NMR chart of compound 1 d.
FIG. 8 is a 13C-NMR chart of compound 1 d.
FIG. 9 is a 1H-NMR chart of compound 1 e.
FIG. 10 is a 13C-NMR chart of compound 1 e.
FIG. 11 is a 1H-NMR chart of compound 1 f.
FIG. 12 is a 1H-NMR chart of compound 1 g.
FIG. 13 is a 1H-NMR chart of compound 1H.
FIG. 14 is a 1H-NMR chart of compound 1 i.
FIG. 15 is a 1H-NMR chart of compound 1 j.
FIG. 16 is a 1H-NMR chart of compound 1 k.
FIG. 17 is a 1H-NMR chart of compound 1 l.
FIG. 18 is a 1H-NMR chart of compound 1 m.
FIG. 19 is a 1H-NMR chart of compound 1 n.
Detailed Description
The following is a further detailed description of the embodiments:
example 1: synthesis of methyl 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzoate (1 a)
Methyl 4- (1-azido vinyl) benzoate (101.5 mg,0.5 mmol) was added to a dry 25mL reaction tube under argon, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added with stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a reaction bath with stirring at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:5) to give methyl 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzoate (1 a) as a yellow solid (99.8 mg, 67%), m.p.137.4-138.3 ℃. 1 H NMR(400MHz,Chloroform-d)δ8.73(s,1H),8.10(d,J=8.6Hz,2H),7.53(d,J=8.6Hz,2H),3.94(s,3H),3.47–3.41(m,1H),3.29–3.22(m,1H),3.04(td,J=16.1,4.9Hz,1H),2.59(q,J=16.1Hz,1H),1.22(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ167.6(t,J=31.2Hz),166.3,144.3(d,J=2.2Hz),130.9,130.5,125.4,116.7(t,J=251.8Hz),88.6(dd,J=8.7,2.0Hz),59.3,52.4(d,J=2.6Hz),47.0(t,J=21.5Hz),15.0. 19 F NMR(376MHz,Chloroform-d)δ-103.1(dt,J=281.5,16.5Hz,1F),-106.53(d,J=275.1Hz,1F).HRMS(ESI)calcad for C 14 H 15 F 2 NNaO 4 + ([M+Na] + ):322.0861,found 322.0872.
Example 2: synthesis of 5-ethoxy-3, 3-difluoro-5- (4-fluorophenyl) pyrrolidin-2-one (1 b)
1- (1-azidoethyl) -4-fluorobenzene (81.5 mg,0.5 mmol) was added to a dry 25mL reaction tube under argon, anhydrous MeCN (5 mL) was added with stirringEthyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added thereto, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a reaction bath with stirring at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:8) to give 5-ethoxy-3, 3-difluoro-5- (4-fluorophenyl) pyrrolidin-2-one (1 b) as a white solid (92.9 mg, 71%), m.p.136.3-137.1 ℃. 1 H NMR(400MHz,Chloroform-d)δ9.19(s,1H),7.43(dd,J=8.7,5.2Hz,2H),7.13(t,J=8.6Hz,2H),3.45–3.38(m,1H),3.29–3.21(m,1H),3.02(td,J=16.3,4.9Hz,1H),2.58(q,J=16.1Hz,1H),1.20(t,J=7.0Hz,3H). 13 C NMR(101MHz,Acetone-d 6 )δ165.6(t,J=30.6Hz),162.8(d,J=245.8Hz),136.5(d,J=2.7Hz),127.9(d,J=8.6Hz),117.3(t,J=249.9Hz),115.5(d,J=21.8Hz),88.0(dd,J=9.5,2.1Hz),58.5,46.8(t,J=21.4Hz),14.6. 19 F NMR(376MHz,Chloroform-d)δ-103.2(dt,J=275.8,13.3Hz,1F),-106.7(dt,J=274.6,15.6Hz,1F),-112.4(s,1F).HRMS(ESI)calcad for C 12 H 12 F 3 NNaO 2 + ([M+Na] + ):282.0712,found 282.0721.
Example 3: synthesis of phenyl 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) acetate (1 c)
Into a dry 25mL reaction tube under argon, phenyl 4- (1-azido vinyl) acetate (101.5 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a reaction bath with stirring at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:6) to give phenyl 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) acetate (1 c) as a white solid (94.6 mg, 64%), m.p.105.2-105.9 ℃. 1 H NMR(400MHz,Chloroform-d)δ8.96(s,1H),7.45(d,J=8.6Hz,2H),7.15(d,J=8.6Hz,2H),3.45–3.37(m,1H),3.30–3.22(m,1H),3.01(td,J=16.3,4.5Hz,1H),2.60(q,J=16.0Hz,1H),2.31(s,3H),1.19(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ169.3,167.5(t,J=31.0Hz),151.1,137.0(d,J=2.2Hz),126.5,122.3,116.8(t,J=252.3Hz),88.5(dd,J=9.0,1.9Hz),59.1,47.2(t,J=21.6Hz),21.1,15.0. 19 F NMR(376MHz,Chloroform-d)δ-103.1(dt,J=276.2,17.1Hz,1F),-106.6(dd,J=274.7,11.8Hz,1F).HRMS(ESI)calcad for C 14 H 15 F 2 NNaO 4 + ([M+Na] + ):322.0861,found 322.0872.
Example 4: synthesis of 5-methoxy-5- (4-ethylphenyl) -3, 3-difluoropyrrolidin-2-one (1 d)
1- (1-azidoethyl) -4-ethylbenzene (86.6 mg,0.5 mmol) was added to a dry 25mL reaction tube under argon, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring at-10 ℃ Drop-down Et 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was maintained at-10 in a low temperature constant temperature stirred reaction bath ℃ The reaction was continued for 3h and the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:10) to give 5-methoxy-5- (4-ethylphenyl) -3, 3-difluoropyrrolidin-2-one (1 d) as a brown oily liquid (85.0 mg, 63%). 1 H NMR(400MHz,Chloroform-d)δ8.51(s,1H),7.33(d,J=8.2Hz,2H),7.26(d,J=8.2Hz,2H),3.43–3.36(m,1H),3.31–3.24(m,1H),3.06–2.97(m,1H),2.70–2.54(m,3H),1.26–1.19(m,6H). 13 C NMR(101MHz,Chloroform-d)δ167.6(t,J=31.2Hz),145.3,136.6(d,J=2.1Hz),128.6,125.1,117.0(t,J=252.4Hz),88.8(dd,J=8.8,2.2Hz),59.0,47.3(t,J=21.3Hz),28.5,15.4,15.1. 19 F NMR(376MHz,Chloroform-d)δ-103.1(dt,J=275.1,16.8Hz,1F),-106.73(dd,J=274.9,16.5Hz,1F).HRMS(ESI)calcad for C 14 H 17 F 2 NNaO 2 + ([M+Na] + ):292.1120,found 292.1118.
Example 5: synthesis of 5- (3-bromophenyl) -5-ethoxy-3, 3-difluoropyrrolidin-2-one (1 e)
1- (1-azidoethyl) -3-bromobenzene (111.5 mg,0.5 mmol) was added to a dry 25mL reaction tube under argon, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added with stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10deg.C in a reaction bath with stirring at a low temperature and constant temperature for further reaction for 3 hours, the reaction solution was concentrated under reduced pressure, and the obtained crude product was purified by silica gel column (ethyl acetate/petroleum ether=1:10) to give 5- (3-bromophenyl) -5-ethoxy-3, 3-difluoropyrrolidin-2-one (1 e) as a white solid (105.5 mg, 66%), m.p.131.9-132.6deg.C. 1 H NMR(400MHz,Chloroform-d)δ8.93(s,1H),7.59(s,1H),7.53(d,J=8.1Hz,1H),7.38(d,J=7.9Hz,1H),7.32(t,J=7.8Hz,1H),3.48–3.40(m,1H),3.31–3.23(m,1H),3.01(td,J=16.2,4.9Hz,1H),2.59(q,J=16.2Hz,1H),1.22(t,J=7.0Hz,3H). 13 C NMR(101MHz,Acetone-d 6 )δ166.4(t,J=30.7Hz),143.9(d,J=2.4Hz),132.7,131.7,129.6,125.5,123.3,118.1(t,J=250.1Hz),88.6(dd,J=9.5,2.2Hz),59.5,47.3(t,J=21.7Hz),15.4. 19 F NMR(376MHz,Chloroform-d)δ-103.1(dt,J=275.8,17.1Hz,1F),-106.6(dd,J=275.8,16.5Hz,1F).HRMS(ESI)calcad for C 12 H 12 BrF 2 NNaO 2 + ([M+Na] + ):341.9920,found 341.9912.
Example 6: synthesis of benzyl 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzoate (1 f)
Benzyl 4- (1-azido vinyl) benzoate (139.6 mg,0.5 mmol) was added to a dry 25mL reaction tube under argon, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added with stirring, and the mixture was stirred at room temperatureEt is added dropwise at 10 DEG C 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a reaction bath with stirring at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:7) to give benzyl 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzoate (1 f), a white solid (118.6 mg, 63%), m.p.119.1-119.5 ℃. 1 H NMR(400MHz,Chloroform-d)δ8.54(s,1H),8.17–7.94(m,2H),7.58(t,J=7.4Hz,1H),7.52(d,J=8.2Hz,2H),7.47–7.43(m,4H),5.38(s,2H),3.46–3.39(m,1H),3.32–3.24(m,1H),3.03(td,J=16.4,4.7Hz,1H),2.60(q,J=16.1Hz,1H),1.22(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ167.6(t,J=31.1Hz),166.4,139.5(d,J=2.2Hz),137.2,133.2,129.8,129.7,128.9,128.4,125.5,116.9(d,J=251.3Hz),88.6(dd,J=8.7,2.0Hz),65.9,59.1,47.2(t,J=21.6Hz),15.1. 19 F NMR(376MHz,Chloroform-d)δ-99.96(dt,J=275.4,17.1Hz,1F),-103.49(dd,J=275.5,16.1Hz,1F).HRMS(ESI)calcad for C 20 H 19 F 2 NNaO 4 + ([M+Na] + ):398.1174,found 398.1184.
Example 7: synthesis of 5-ethoxy-3, 3-difluoro-5- (thiophen-3-yl) pyrrolidin-2-one (1 g)
Under the protection of argon, 3- (1-azidoethyl) thiophene (75.5 mg,0.5 mmol) was added to a dry 25mL reaction tube, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10deg.C in a reaction bath with stirring at a low temperature and constant temperature for further reaction for 3 hours, the reaction solution was concentrated under reduced pressure, and the obtained crude product was purified by silica gel column (ethyl acetate/petroleum ether=1:10) to give 5-ethoxy-3, 3-difluoro-5- (thiophen-3-yl) pyrrolidin-2-one (1 g), as a white solid (82.2 mg, 67%), m.p.110.7-111.4deg.C. 1 H NMR(400MHz,Chloroform-d)δ8.71(s,1H),7.40(dd,J=5.0,3.0Hz,1H),7.34(dd,J=2.9,1.3Hz,1H),7.07(dd,J=5.0,1.2Hz,1H),3.46–3.38(m,1H),3.34–3.26(m,1H),3.07–2.98(m,1H),2.75–2.64(m,1H),1.19(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ167.4(t,J=31.1Hz),141.2(d,J=2.4Hz),127.9,125.0,122.7,116.9(dd,J=252.5,251.1Hz),86.7(dd,J=8.8,2.5Hz),59.2,46.4(t,J=21.6Hz),15.1. 19 F NMR(376MHz,Chloroform-d)δ-102.8(d,J=275.5Hz,1F),-106.4(d,J=275.5Hz,1F).HRMS(ESI)calcad for C 10 H 11 F 2 NNaO 2 S + ([M+Na] + ):270.0381,found 270.0371.
Example 8: synthesis of propyl 3- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzoate (1 h)
Into a dry 25mL reaction tube under argon protection, 4-azidopent-4-en-1-yl benzoate (115.6 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring, et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a stirred reaction bath at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:4) to give propyl 3- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzoate (1 h), a white solid (108.3 mg, 66%), m.p.64.4-65.1 ℃. 1 H NMR(400MHz,Chloroform-d)δ8.03(d,J=7.3Hz,2H),7.67(s,1H),7.57(t,J=7.4Hz,1H),7.45(t,J=7.7Hz,2H),4.36(t,J=6.0Hz,2H),3.48–3.37(m,2H),2.77–2.66(m,1H),2.60–2.48(m,1H),2.08–1.86(m,4H),1.19(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ166.5,166.0(t,J=30.5Hz),133.1,129.9,129.5,128.4,117.0(dd,J=251.7,250.3Hz),87.3(dd,J=7.0,3.2Hz),64.1,57.6,41.0(t,J=21.9Hz),36.4(d,J=2.0Hz),22.8,15.1. 19 F NMR(376MHz,Chloroform-d)δ-102.8(dd,J=276.8,12.9Hz,1F),-104.6(dd,J=276.3,10.0Hz,1F).HRMS(ESI)calcad for C 16 H 19 F 2 NNaO 4 + ([M+Na] + ):350.1174,found 350.1178.
Example 9: synthesis of 5-cyclohexyl-5-ethoxy-3, 3-difluoropyrrolidin-2-one (1 i)
Under the protection of argon, in a dry 25mL reaction tube, (1-azido vinyl) cyclohexane (75.6 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring, et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10deg.C in a reaction bath with stirring at a low temperature and constant temperature for further reaction for 3 hours, the reaction solution was concentrated under reduced pressure, and the obtained crude product was purified by silica gel column (ethyl acetate/petroleum ether=1:10) to give 5-cyclohexyl-5-ethoxy-3, 3-difluoropyrrolidin-2-one (1 i) as a white solid (64.2 mg, 52%), m.p.71.3-71.9 ℃. 1 H NMR(400MHz,Chloroform-d)δ7.74(s,1H),3.44–3.32(m,2H),2.65–2.45(m,2H),1.80(d,J=11.5Hz,3H),1.72–1.66(m,3H),1.28–0.99(m,8H). 13 C NMR(101MHz,Chloroform-d)δ166.1(t,J=30.9Hz),117.2(t,J=250.6Hz),89.9(dd,J=7.3,2.8Hz),57.1,45.6(d,J=1.8Hz),38.2(t,J=21.9Hz),26.7,26.3,26.1,25.81,25.80,15.1. 19 F NMR(376MHz,Chloroform-d)δ-101.8–-102.6(m,1F),-104.4–-105.2(m,1F).HRMS(ESI)calcad for C 12 H 19 F 2 NNaO 2 + ([M+Na] + ):270.1276,found 270.1280.
Example 10: synthesis of methyl 5- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) pentanoate (1 j)
Under the protection of argon, in a dry 25mL reaction tube, (1-azido vinyl) cyclohexane (91.6 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring, et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was maintained at-10℃in a stirred reaction bath at a low temperatureThe reaction was continued for 3h, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:4) to give methyl 5- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) pentanoate (1 j) as a yellow oily liquid (71.5 mg, 57%). 1 H NMR(400MHz,Chloroform-d)δ7.63(s,1H),3.65(s,3H),3.43–3.32(m,2H),2.69–2.59(m,1H),2.53–2.41(m,1H),2.32(t,J=7.3Hz,2H),1.90–1.82(m,1H),1.78–1.72(m,1H),1.68–1.60(m,2H),1.44–1.36(m,2H),1.15(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ173.8,165.9(t,J=30.9Hz),117.1(t,J=250.2Hz),87.4(dd,J=7.1,3.1Hz),57.5,51.6,41.0(t,J=21.7Hz),39.1(d,J=2.2Hz),33.6,24.5,22.6,15.1. 19 F NMR(376MHz,Chloroform-d)δ-103.1(dd,J=275.2,15.4Hz,1F),-105.4(d,J=276.1Hz,1F).HRMS(ESI)calcad for C 12 H 19 F 2 NNaO 4 + ([M+Na] + ):302.1174,found 302.1179.
Example 11: synthesis of 5-ethoxy-3, 3-difluoro-5-hexylpyrrolidin-2-one (1 k)
Into a dry 25mL reaction tube under argon, 2-azidooctan-1-ene (76.6 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added under stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a stirred reaction bath at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:8) to give 5-ethoxy-3, 3-difluoro-5-hexylpyrrolidin-2-one (1 k) as a colorless oily liquid (59.5 mg, 58%). 1 H NMR(400MHz,Chloroform-d)δ7.48(s,1H),3.45–3.34(m,2H),2.71–2.61(m,1H),2.56–2.44(m,1H),1.90–1.83(m,1H),1.75–1.68(m,1H),1.37–1.28(m,8H),1.18(t,J=7.0Hz,3H),0.88(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ166.2(t,J=31.5Hz),117.3(t,J=250.7Hz),87.7(dd,J=7.2,2.8Hz),57.5,41.2(t,J=21.7Hz),39.1,31.5,29.0,23.1,22.5,15.2,14.0. 19 F NMR(376MHz,Chloroform-d)δ-103.0(dt,J=275.7,15.9Hz,1F),-105.0–-105.8(m,1F).HRMS(ESI)calcad for C 12 H 21 F 2 NNaO 2 + ([M+Na] + ):272.1433,found 272.1441.
Example 12: synthesis of 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzyl 4- (N, N-di-N-propylamine sulfonyl) benzoate (1 l)
Into a dry 25mL reaction tube under argon, 4- (1-azidoethyl) benzyl 4- (N, N-di-N-propylaminosulfonyl) benzoate (221.1 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added with stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane), kept at-10℃in a reaction bath with stirring at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:4) to give 4- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) benzyl 4- (N, N-di-N-propylaminosulfonyl) benzoate (1L), colorless oily liquid (181.9 mg, 68%). 1 H NMR(400MHz,Chloroform-d)δ8.79(s,1H),8.19(d,J=8.6Hz,2H),7.88(d,J=8.6Hz,2H),7.52(d,J=8.3Hz,2H),7.47(d,J=8.4Hz,2H),5.40(s,2H),3.46–3.39(m,1H),3.31–3.23(m,1H),3.11–2.98(m,5H),2.60(q,J=16.2Hz,1H),1.58–1.49(m,4H),1.21(t,J=7.0Hz,3H),0.86(t,J=7.4Hz,6H). 13 C NMR(101MHz,Chloroform-d)δ167.7(t,J=29.6Hz),165.0,144.3,139.8,136.5,133.1,130.3,129.1,127.0,125.6,116.9(t,J=252.1Hz),88.6(dd,J=8.7,1.8Hz),66.5,59.1,49.8,47.1(t,J=21.6Hz),21.8,15.0,11.1. 19 F NMR(376MHz,Chloroform-d)δ-103.6(dt,J=275.4,17.0Hz,1F),-107.1(dd,J=275.2,16.4Hz,1F).HRMS(ESI)calcad for C 26 H 32 F 2 N 2 NaO 6 S + ([M+Na] + ):561.1846,found 561.1841.
Example 13: synthesis of 5- ((3, 5-dimethylphenoxy) methyl) -3- (3- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) propyl) oxazolidin-2-one (1 m)
Into a dry 25mL reaction tube under argon, 3- (4-azidopent-4-en-1-yl) -5- ((3, 5-dimethylphenoxy) methyl) oxazolidin-2-one (165.1 mg,0.5 mmol) was added, anhydrous MeCN (5 mL) was added, ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) was added with stirring, and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10℃in a stirred reaction bath at a low temperature for 3 hours, the reaction mixture was concentrated under reduced pressure, and the crude product obtained was purified by silica gel column (ethyl acetate/petroleum ether=1:3) to give 5- ((3, 5-dimethylphenoxy) methyl) -3- (3- (2-ethoxy-4, 4-difluoro-5-oxopyrrolidin-2-yl) propyl) oxazolidin-2-one (1 m) as a white solid (111.2 mg, 52%), m.p.103.6-104.8 ℃. 1 H NMR(500MHz,Chloroform-d)δ7.40(s,1H),6.64(s,1H),6.52(s,2H),4.86–4.80(m,1H),4.13–4.07(m,2H),3.70(t,J=8.8Hz,1H),3.56(dd,J=8.6,5.8Hz,1H),3.42–3.27(m,4H),2.70–2.62(m,1H),2.54–2.44(m,1H),2.28(s,6H),1.90–1.81(m,2H),1.72–1.64(m,2H),1.16(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ165.6(t,J=30.7Hz),158.0,157.9,139.4,123.3,117.0(t,J=250.0Hz),112.2,87.1(dd,J=5.9,3.1Hz),71.0,67.9,57.5,46.3,43.5,40.8(t,J=21.4Hz),36.2,21.3,21.2,15.1. 19 F NMR(376MHz,Chloroform-d)δ-102.8(d,J=275.1Hz,1F),-104.3–-105.1(m,1F).HRMS(ESI)calcad for C 21 H 28 F 2 N 2 NaO 5 + ([M+Na] + ):449.1858,found 449.1868.
Example 14: synthesis of 5- (benzofuran-5-yl) -5-ethoxy-3, 3-difluoropyrrolidin-2-one (1 n)
Under the protection of argon, adding into a dry 25mL reaction tube5- (1-azidoethyl) benzofuran (92.5 mg,0.5 mmol), anhydrous MeCN (5 mL) and ethyl difluoroiodoacetate (77.0. Mu.L, 0.6 mmol) were added with stirring and Et was added dropwise at-10 ℃ 2 Zn (0.25 mL,0.25mmol,1.0mol/L in hexane) was kept at-10deg.C in a reaction bath with stirring at a low temperature and constant temperature for further reaction for 3 hours, the reaction solution was concentrated under reduced pressure, and the obtained crude product was purified by silica gel column (ethyl acetate/petroleum ether=1:8) to give 5- (benzofuran-5-yl) -5-ethoxy-3, 3-difluoropyrrolidin-2-one (1 n), as a white solid (91.7 mg, 65%), m.p.113.9-114.7deg.C. 1 H NMR(400MHz,Chloroform-d)δ8.87(s,1H),7.69(d,J=2.0Hz,2H),7.56(d,J=8.7Hz,1H),7.38(dd,J=8.7,1.9Hz,1H),6.82(d,J=2.1Hz,1H),3.48–3.40(m,1H),3.33–3.26(m,1H),3.13–3.03(m,1H),2.72–2.60(m,1H),1.22(t,J=7.0Hz,3H). 13 C NMR(101MHz,Chloroform-d)δ167.8(t,J=31.2Hz),154.9,146.2,134.2(d,J=2.0Hz),127.9,121.5,118.2,117.1(dd,J=253.4,251.0Hz),112.2,106.8,89.1(dd,J=8.8,2.2Hz),59.1,47.7(t,J=21.3Hz),15.1. 19 F NMR(376MHz,Chloroform-d)δ-103.1(dt,J=275.3,16.2Hz,1F),-106.6(dd,J=275.5,16.1Hz,1F).HRMS(ESI)calcad for C 14 H 13 F 2 NNaO 3 + ([M+Na] + ):304.0756,found 304.0764.
The foregoing is merely exemplary embodiments of the present application, and specific structures and features that are well known in the art are not described in detail herein. It should be noted that modifications and improvements can be made by those skilled in the art without departing from the structure of the present application, and these should also be considered as the scope of the present application, which does not affect the effect of the implementation of the present application and the utility of the patent. The protection scope of the present application is subject to the content of the claims, and the description of the specific embodiments and the like in the specification can be used for explaining the content of the claims.
Claims (8)
1. A process for preparing 3, 3-difluoro-gamma-lactam compound features that vinyl azide and ethyl difluoroiodoacetate are used as raw materials and are used in Et 2 In the presence of Zn, in anhydrous acetonitrile at-10 deg.c for 3 hr to synthesize a series of C-5 quaternary carbon centers3, 3-difluoro-gamma-lactam compound of formula:
wherein R is one of a substituted or unsubstituted aryl group and a substituted or unsubstituted alkyl group.
2. The method of manufacturing according to claim 1, characterized in that: the "substitution" in the "substituted or unsubstituted" means that at least one hydrogen atom on the group is substituted with a group selected from the group consisting of: hydrogen atom, halogen atom, methyl, ethyl, propyl, butyl, methoxy, acetyl, acetoxy, methoxycarbonyl, benzoyloxymethyl, tert-butyl, benzoyloxy.
3. The method of manufacturing according to claim 1, characterized in that: r is selected from phenyl, 4-fluorophenyl, 4-chlorophenyl, 4-bromophenyl, 4-methylphenyl, 4-ethylphenyl, 4-methoxyphenyl, 4-acetylphenyl, 4-acetoxyphenyl, 4-methoxycarbonylphenyl, 4-benzoyloxymethylphenyl, 4-tert-butylphenyl, biphenyl, 3-methylphenyl, 3-bromophenyl; 3-thienyl, 5-benzofuranyl, R is selected from cyclohexyl, n-hexyl, 4-methoxycarbonyl n-butyl or 3-benzoyloxy n-propyl.
4. A process according to any one of claims 1 to 3, characterized in that: the above reaction was carried out under argon.
5. The method of manufacturing according to claim 4, wherein: concentrating under vacuum after the reaction is finished; eluting with petroleum ether/ethyl acetate, and separating with silica gel column to obtain 3, 3-difluoro-gamma-lactam compound.
6. The method of manufacturing according to claim 5, wherein: the molar ratio of the ethyl difluoroiodoacetate to the vinyl azide is 1.2:1.
7. The method of manufacturing according to claim 6, wherein: said Et 2 The molar ratio of Zn to vinyl azide was 0.5:1.
8. The method of manufacturing according to claim 7, wherein: the addition amount of the anhydrous acetonitrile is 200 times that of the vinyl azide.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310595622.2A CN116621756A (en) | 2023-05-24 | 2023-05-24 | Preparation method of 3, 3-difluoro-gamma-lactam compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310595622.2A CN116621756A (en) | 2023-05-24 | 2023-05-24 | Preparation method of 3, 3-difluoro-gamma-lactam compound |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116621756A true CN116621756A (en) | 2023-08-22 |
Family
ID=87591398
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310595622.2A Pending CN116621756A (en) | 2023-05-24 | 2023-05-24 | Preparation method of 3, 3-difluoro-gamma-lactam compound |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116621756A (en) |
-
2023
- 2023-05-24 CN CN202310595622.2A patent/CN116621756A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107739353B (en) | A kind of synthetic method of 2,3,5- trisubstituted furans | |
CN105906537B (en) | (Z)The One-step Synthesis method of formula sulfonyl enoic acid ester compounds | |
CN113861137B (en) | Method for synthesizing furan compound by one-step reaction of ketone and alpha chloroketone | |
CN112142694A (en) | Polysubstituted tetrahydrofuran and tetrahydropyrane diene compound and preparation method thereof | |
CN112209905A (en) | Polysubstituted alpha-alkenyl lactone compound, preparation method and application thereof | |
CN107793385A (en) | A kind of synthetic method of furan derivatives | |
KR100483775B1 (en) | Process for the preparation of ascorbic acid | |
CN111763163B (en) | Preparation method of diphenyl disulfide compound | |
CN113912577A (en) | Lockmilanol intermediate, Lockmilanol and derivatives thereof, preparation and application | |
CN111689887B (en) | Copper/iridium concerted catalysis asymmetric allylation/2-aza-Cope rearrangement reaction and application thereof | |
CN116621756A (en) | Preparation method of 3, 3-difluoro-gamma-lactam compound | |
CN110511193A (en) | A kind of α -one thioamide analog compound and its synthetic method | |
CN113045530B (en) | Method for preparing naphthopyran compounds by ruthenium catalysis | |
CN111662147B (en) | Process for preparing diynes and analogues thereof | |
CN108947995B (en) | Preparation method of polysubstituted oxadiazine derivative | |
CN114044786A (en) | N1-bora 1,2, 3-triazole compound and preparation method thereof | |
CN112300035B (en) | Preparation method of dithioacetal derivative | |
CN113943281B (en) | Synthetic method and application of isoxazole pyrimidine derivative | |
CN115028505B (en) | Preparation method of beta, beta-di (hetero) aryl-alpha, alpha-difluoro ketone compound | |
CN109761842B (en) | Synthesis method of alpha-F-beta-NHAc-carbonyl compound | |
JP7168161B2 (en) | Method for producing heterol multimer | |
CN116768852A (en) | Preparation method of benzo [ b ] selenophene derivative | |
JP3231207B2 (en) | Method for producing sulfenylacetic acid derivative | |
Davis | Synthesis of Chiral Cyclopentanones through Reactions with Vinyl Sulfoxonium Salts | |
SU1576524A1 (en) | Method of obtaining derivatives of tetralon-2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |